Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Our products& pipeline
    • Diseases we target
    • GS010 for LHON
    • GS030 for Retinitis Pigmentosa
    • GS030 for Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
  • Investors& media
    • Company Overview
    • Press releases
    • Events & presentations
    • News and press coverage
    • Stock information
    • Governance
    • Documentation

Events & presentations

13 Nov 2020 - 15 Nov 2020

American Academy of Ophthalmology 2020 – Virtual

06 Nov 2020

Eyecelerator 2020 – Virtual Conference

02 Nov 2020 - 05 Nov 2020

World Orphan Drug Congress Europe 2020 – Live Digital

26 Oct 2020 - 28 Oct 2020

4th Annual Gene Therapy for Rare Disorders Europe – Virtual

26 Oct 2020 - 29 Oct 2020

BioEurope – Digital

12 Oct 2020 - 16 Oct 2020

Cell & Gene Meeting on the Mesa – Virtual

05 Oct 2020 - 06 Oct 2020

Chardan 4th Annual Genetic Medicines Conference – Virtual

05 Oct 2020 - 06 Oct 2020

HealthTech Innovation Days (HTID®), Paris, France & Virtual Conference

02 Oct 2020 - 04 Oct 2020

EURETINA 2020 – Virtual

30 Sep 2020

Ophthalmology Futures Retina – Virtual Forum

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 16
  • View next 9 articles
© 2022 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page